A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT02204085 · COMPLETED

Trial details

NCT number: NCT02204085
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Recurrent Adult Acute Myeloid Leukemia

Start date: 2014-09-01
Primary completion: 2025-09-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.